In pancreatic and ovarian cancers, nuclear TFEB activation supports metabolic flexibility and alters inflammasome dynamics, leading to reduced immunogenicity and increased survival under cytotoxic stress.48 The gene discussed is TFEB; the disease is ovarian carcinoma.